Potential of Psilocybin ('Magic Mushrooms') to Enhance Motor Function and Mood in Parkinson's Disease Patients

Recent research from the University of California, San Francisco explores the promising effects of psilocybin, a compound derived from certain mushrooms, in managing symptoms of Parkinson's disease beyond traditional treatments. Recognized primarily for its role in treating depression and anxiety, psilocybin is now being investigated for its potential to improve motor functions and mood disturbances commonly experienced by Parkinson's patients.
In a pioneering pilot study, UCSF researchers administered controlled doses of psilocybin to a small group of participants with mild to moderate Parkinson's. The study involved seven men and five women who received a 10 mg dose initially, followed by a 25 mg dose two weeks later. Participants engaged in psychotherapy sessions surrounding the drug administration, with evaluations conducted over subsequent weeks.
Results indicated that the participants tolerated the treatment well, with no serious adverse effects or worsening of symptoms. Remarkably, they exhibited significant, lasting improvements in mood, cognition, and motor symptoms that persisted for weeks post-treatment. Follow-ups three months after the sessions confirmed sustained mood enhancement. The improvements could be due to psilocybin's ability to promote neuroplasticity and reduce inflammation, potentially facilitating brain repair.
These findings are groundbreaking as they represent the first instance of a psychedelic being tested in patients with a neurodegenerative disease. The positive outcomes have spurred ongoing research, including a larger, multi-center trial at UCSF and Yale University, aiming to enroll 100 participants. This expanded study seeks to utilize neuroimaging and brain stimulation techniques to better understand how psilocybin influences neurodegeneration.
Parkinson's disease affects over one million Americans, characterized by symptoms such as tremors and difficulty walking. Often, psychological symptoms like anxiety and depression may predict physical decline more strongly than motor issues, yet standard medications frequently fall short in addressing these aspects.
The new research underscores the potential for psilocybin not only to alleviate mood and cognitive symptoms but also to provide benefits in motor functions—effects that could modify the disease trajectory. While still in early stages, this work offers hope for new therapeutic avenues that could transform healthcare approaches for neurodegenerative disorders.
source: https://medicalxpress.com/news/2025-04-magic-mushrooms-motor-function-mood.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Exploring Low-Dose Naltrexone as a Potential Treatment for Long COVID
Research from Griffith University suggests that low-dose naltrexone, a drug used for opioid addiction, may be an effective treatment for Long COVID by restoring cellular function and improving symptoms.
Enhanced Access to Social Support Programs Boosts Treatment for Women with Drug Use Disorders
A new study reveals that combining Medicaid with social support services significantly increases treatment access for women with drug and opioid use disorders. Expanded social safety net programs can help address treatment gaps and barriers faced by women with substance use issues.
Empowering Africa's Surveillance Labs to Accelerate Polio Eradication
Africa's strengthening surveillance laboratories and dedicated frontline workers are crucial in the ongoing fight to eradicate polio. Strategic investments and regional collaboration can help overcome persistent challenges and secure a polio-free future for the continent.
The Impact of Snooze Alarms on Sleep Quality and Wakefulness
A new global study highlights how snooze alarms disrupt critical sleep stages and impact morning alertness, emphasizing the importance of setting a consistent, early wake-up time.